Genetic analysis reveals potential benefit of aspirin for reducing dementia risk
Low-dose aspirin was associated with a 70% lower risk of dementia among older people with a particular genetic profile, a new Monash University analysis has found, raising the possibility of a more personalized approach to dementia prevention.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Even short-term rises in air pollution are linked to more asthma emergency visits in Singapore
United Kingdom
-
Blood RNA markers may flag lung cancer risk 10 years before diagnosis
United Kingdom
-
Personalized navigation support increases genetic testing among cancer patients' relatives
United Kingdom
-
New AI framework personalizes supportive care for cancer survivors
United Kingdom
-
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
United Kingdom
-
Heart health guidance shifts focus from individual nutrients to overall diet quality
United Kingdom
-
Focusing on the 'obesity paradox' to improve cancer treatment success
United Kingdom
-
Focused brain radiation could ease severe, tough-to-treat depression
United Kingdom